Recent news from Barcelona: As a function of the very first Global Think Tank on Steatotic Liver Disease, supported by the Barcelona Institute for Global Health (ISGlobal) and held in the Palau Macaya of Barcelona on June 5-6, 2025, 100+ international experts issued a clear warning: millions of people will continue to go unseen by healthcare systems unless early detection and person-centred care for liver disease are prioritized soonest.
The experts propose concrete actions to address this public health threat by 2030, including updating reimbursement policies and fostering collaboration across primary care, hepatology, and metabolic health sectors. Without immediate attention and systemic changes, millions may continue to suffer from undiagnosed and untreated liver diseases, leading to increased mortality and healthcare burdens.
The future of the fight against MASH lies in anticipation: not only treating advanced patients but also identifying those without fibrosis early on. This shift towards preventive hepatology is key to improving the metabolic health of millions around the world,” says Jeffrey Lazarus, Head of the Public Health Liver Group at ISGlobal, a centre supported by the “la Caixa” Foundation, and lead author of the study.
